DRUG DESCRIPTION. LEVEMIRÂ® (insulin detemir [rDNA origin] injection) is a sterile solution of insulin detemir for use as a subcutaneous injection. Insulin detemir is a long-acting (up to 24-hour duration of action) recombinant human insulin analog. LEVEMIRÂ® is produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae followed by chemical modification.
The UV Index is a linear scale, with higher values representing a greater risk of sunburn (which is correlated with other health risks) due to UV exposure. An index of 0 corresponds to zero UV radiation, as is essentially the case at night.
In 1992 the Atmospheric and Environment Service (AES) of Canada began issuing their own UV Index (Wilson, 1993), a next day forecast of UV exposure on a scale of 0 - 10 (where 10 is the highest value likely in southern Canada).